← Back to All Stocks

Sangamo Therapeutics, Inc. (SGMO) Analysis

Generated on: 2025-07-16 15:07:40 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$0.49
Predicted Price
$0.55
Expected Return
10.95%
Confidence Score
0.83
RSI (14)
19.55 (buy)
MACD
-0.01
Volume
524,417
Float Shares
226,864,469
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

SGMO

Sangamo Therapeutics, Inc.
10.95%
Price: $0.49
Confidence: 0.83
News
RSI Buy
Last updated: 2025-07-16 15:07:40

Technical Analysis

RSI: 19.55 (buy)
MACD: -0.01
Technical Analysis Graph

Risk Analysis

Volatility
153.47%
Max Drawdown
-85.02%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
H.C. Wainwright Reaffirms Buy Rating on Sangamo After Promising Gene Therapy Data
Insider Monkey - 2025-07-03 13:18
Sangamo Therapeutics Inc. (NASDAQ:SGMO) ranks among the best CRISPR stocks to buy. Following the release of Sangamo Therapeutics Inc. (NASDAQ:SGMO)’s top-line findings from its Phase 1/2 STAAR study, H.C. Wainwright reaffirmed its Buy rating and $10 price target on the company on June 25. Adults with Fabry disease were treated with isaralgagene civaparvovec (ST-920 or […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.